Collaboration to Develop Novel Class of Drug Conjugate
Collaboration to Develop Novel Class of Drug Conjugate😎
"The Affimer-drug conjugate circulates as a single molecule, in which the conjugated drug is inert, until it encounters enzymes selectively expressed in tumours, where the drug is released and through its mechanism of action is designed to turn immunologically “cold” tumours “hot” and receptive to immunotherapy. It is our expectation that this will increase the percentage of responsive patients dramatically and in doing so, it will make a meaningful difference to the lives of a great many cancer patients.”
https://www.labmate-online.com/news/news-and-views/5/avacta-group/collaboration-to-develop-novel-class-of-drug-conjugate/46762
"The Affimer-drug conjugate circulates as a single molecule, in which the conjugated drug is inert, until it encounters enzymes selectively expressed in tumours, where the drug is released and through its mechanism of action is designed to turn immunologically “cold” tumours “hot” and receptive to immunotherapy. It is our expectation that this will increase the percentage of responsive patients dramatically and in doing so, it will make a meaningful difference to the lives of a great many cancer patients.”
https://www.labmate-online.com/news/news-and-views/5/avacta-group/collaboration-to-develop-novel-class-of-drug-conjugate/46762
Comments